Aurora Cannabis Expands Discount Program and Analyst Forecasts Diverge on Potential Upside or Downside
ByAinvest
Saturday, Jun 28, 2025 5:44 pm ET1min read
ACB--
The changes to the compassionate pricing program are available alongside new medical cannabis products, including Aurora | Mediora Minis – Cannatonic CBD Flower, Sativa (10mg), Daily Special | Sativa J's - THC Pre-Rolls, Sativa (7 x 0.3g), and WMMC | Seasonal Stash Petro Biscuit – THC Flower, Indica (10mg) [1]. Aurora also offers resources to seniors, pediatric patients, veterans, first responders, and others seeking care through medical cannabis [1].
Aurora's stock price has seen a notable uptick following this strategic revision, with analysts forecasting a potential downside of 26.00% from the current trading price of $4.30 [2]. However, GuruFocus estimates suggest a contrasting potential upside of 37.09%, indicating different valuation perspectives [2]. The average one-year price target for Aurora Cannabis Inc. (ACB) stands at $3.18, with a consensus brokerage recommendation of 2.3, positioning it in the "Outperform" category [2].
Aurora's commitment to accessible medical cannabis is evident in its ongoing initiatives. The company continues to provide tailored resources for special demographic groups, reinforcing its role in breaking down barriers to high-quality cannabis. Patients can visit www.auroramedical.com for more information and to connect with the Aurora client care team [1].
References:
[1] https://www.cannabisbusinesstimes.com/industry-headlines/news/15749509/aurora-expands-patient-access-to-medical-cannabis-in-canada-with-extended-compassionate-pricing-program
[2] https://www.gurufocus.com/news/2948935/aurora-cannabis-acb-expands-discount-program-in-canada?mobile=true
[3] https://www.gurufocus.com/news/2947242/aurora-expands-patient-access-to-medical-cannabis-in-canada-with-extended-compassionate-pricing-program-acb-stock-news
Aurora Cannabis has expanded its discount program in Canada, increasing the income eligibility for compassionate pricing from $40,000 to $60,000, potentially boosting access to medical cannabis. Analysts forecast a potential downside for the stock price, while GuruFocus estimates suggest a contrasting potential upside. The company's stock price has risen following the strategic revision.
Aurora Cannabis Inc. (ACB) has recently expanded its compassionate pricing program in Canada, raising the annual income eligibility threshold from CA$40,000 to CA$60,000 [1]. This strategic move aims to enhance accessibility to medical cannabis products, providing a 30% discount to qualifying patients [2]. The program's expansion is expected to benefit over half of the adult population in Canada, making it the most inclusive medical cannabis pricing program in the country [3].The changes to the compassionate pricing program are available alongside new medical cannabis products, including Aurora | Mediora Minis – Cannatonic CBD Flower, Sativa (10mg), Daily Special | Sativa J's - THC Pre-Rolls, Sativa (7 x 0.3g), and WMMC | Seasonal Stash Petro Biscuit – THC Flower, Indica (10mg) [1]. Aurora also offers resources to seniors, pediatric patients, veterans, first responders, and others seeking care through medical cannabis [1].
Aurora's stock price has seen a notable uptick following this strategic revision, with analysts forecasting a potential downside of 26.00% from the current trading price of $4.30 [2]. However, GuruFocus estimates suggest a contrasting potential upside of 37.09%, indicating different valuation perspectives [2]. The average one-year price target for Aurora Cannabis Inc. (ACB) stands at $3.18, with a consensus brokerage recommendation of 2.3, positioning it in the "Outperform" category [2].
Aurora's commitment to accessible medical cannabis is evident in its ongoing initiatives. The company continues to provide tailored resources for special demographic groups, reinforcing its role in breaking down barriers to high-quality cannabis. Patients can visit www.auroramedical.com for more information and to connect with the Aurora client care team [1].
References:
[1] https://www.cannabisbusinesstimes.com/industry-headlines/news/15749509/aurora-expands-patient-access-to-medical-cannabis-in-canada-with-extended-compassionate-pricing-program
[2] https://www.gurufocus.com/news/2948935/aurora-cannabis-acb-expands-discount-program-in-canada?mobile=true
[3] https://www.gurufocus.com/news/2947242/aurora-expands-patient-access-to-medical-cannabis-in-canada-with-extended-compassionate-pricing-program-acb-stock-news

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet